Showing results (121-130 of 761) with videos related to
Sort By:
Pageof 77
Nature Reviews. Nephrology|October 27, 2009
Transplantation: time to rethink immunosuppression by mTOR inhibitors?Marcus D Säemann, Giuseppe RemuzziBMC Nephrology|July 13, 2016
Diets for patients with chronic kidney disease, should we reconsider?William E Mitch, Giuseppe RemuzziJournal of the American Society of Nephrology : JASN|October 11, 2017
Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic SyndromeElena Goicoechea de Jorge, Agustín Tortajada, Sheila Pinto García, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 10, 2017
Hemolytic Uremic Syndrome in Pregnancy and PostpartumAlexandra Bruel, David Kavanagh, Marina Noris, et al.Journal of the American Society of Nephrology : JASN|February 1, 2008
The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndromeRuben Martinez-Barricarte, Gaia Pianetti, Ruxandra Gautard, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2011
Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplantsBarbara Imberti, Federica Casiraghi, Daniela Cugini, et al.Pediatric Nephrology (Berlin, Germany)|July 3, 2008
Complement and the atypical hemolytic uremic syndrome in childrenChantal Loirat, Marina Noris, Véronique Fremeaux-BacchiAge (Dordrecht, Netherlands)|May 10, 2012
Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevityAriela Benigni, Silvia Orisio, Marina Noris, et al.Frontiers in Immunology|March 30, 2026
Molecular determinants of STEC-HUS: from complement activation to microvascular thrombosisDonata Santarsiero, Miriam Galbusera, Sara Gastoldi, et al.Blood Advances|December 1, 2021
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Sistiana Aiello, Sara Gastoldi, Miriam Galbusera, et al.Pageof 77